Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reducing the risk of late relapse in postmenopausal women with hormone-sensitive breast cancer - extended adjuvant letrozole

Reducing the risk of late relapse in postmenopausal women with hormone-sensitive breast cancer - extended adjuvant letrozole. US Oncological Disease 2006, Issue II. 2006; (2):13-16.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.